2020 Annual Meeting | C19 - Neurogenetics: Diagnostic Dilemmas and Therapeutic Implications

Date Saturday 04/25/20

Time 09:30 AM - 11:30 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Fuki M. Hisama, MD, FAAN

Topic(s) General Neurology, Child Neurology and Developmental Neurology

Learning Objectives Participants will understand when is it appropriate to order a single gene test, gene panel, microarray, exome, or genome; be able to describe the importance of counseling, as well as clinician-laboratory interaction in diagnosis; recognize when to implement therapies based on genetic test results; and be able to make appropriate referrals for complex findings as well as describe the basis for the ACMG recommendations for non-neurologic secondary findings from exome and genome sequencing.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Other

Event Timeline
09:30 AM - 09:55 AM	Speaker	Neurogenetic Testing in Child Neurology Andrea L. Gropman, MD, FAAN
09:55 AM - 10:15 AM	Speaker	Genetic Counseling in Pediatric Epilepsy
10:15 AM - 10:40 AM	Speaker	Neurogenetic Testing and Secondary Findings in Adult Neurology Fuki M. Hisama, MD, FAAN
10:40 AM - 11:05 AM	Speaker	Advanced Diagnostics Transforming Neurology Patient Care Edward I. Ginns, MD, PhD, FAAN
11:05 AM - 11:30 AM	Discussion	Panel Discussion With Questions and Answers

Faculty Disclosures
Fuki M. Hisama, MD, FAAN	An immediate family member of Dr. Hisama has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. The institution of Dr. Hisama has received research support from UW Brotman Baty Precision Medicine Institute. The institution of Dr. Hisama has received research support from NIH/NHGRI.
Andrea L. Gropman, MD, FAAN	Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Change Health Care. Dr. Gropman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cyprium. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health. The institution of Dr. Gropman has received research support from O'Malley Family Foundation.
Edward I. Ginns, MD, PhD, FAAN	No disclosure on file
	No disclosure on file

��ɫ��

��ɫ��